StockData
Compugen Ltd logo

Compugen Ltd (CGEN) stock

CGENNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 20-F on Mar 2, 2026Score 12/30
$1.96−0.06 (-2.97%)

Close on Nov 18, 2026Market cap $185.32MP/E 5.2Yield –

Compugen pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Compugen's pe ratio was 5.5× on Nov 11, 2026.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20265.5×–

More Compugen figures

See a number that looks wrong?